UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immunologic components in human milk and allergic diseases with focus on food allergy

Seminars in perinatology, 2021-03, Vol.45 (2), p.151386-151386, Article 151386

2021

Volltextzugriff (PDF)

Cow’s Milk Protein Allergy in Term and Preterm Infants: Clinical Manifestations, Immunologic Pathophysiology, and Management Strategies

Neoreviews (Elk Grove Village, Ill.), 2020-12, Vol.21 (12), p.e795-e808

2020

Volltextzugriff (PDF)

Association of oral habits with food allergy and comorbid atopic disease

Annals of allergy, asthma, & immunology, 2020-08, Vol.125 (2), p.230-231

2020

Volltextzugriff (PDF)

Oral Habits and Association with Lower Rate of Asthma and Seasonal Allergies

Journal of allergy and clinical immunology, 2018-02, Vol.141 (2), p.AB221-AB221

2018

Volltextzugriff (PDF)

Is It Time to Offer Peanut Oral Immunotherapy to Toddlers?

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2021-03, Vol.9 (3), p.1357-1358

2021

Volltextzugriff (PDF)

Association of Oral Habits with Food Allergy and Co-morbid Atopic Disease

Annals of allergy, asthma, & immunology, 2020-05

2020

Volltextzugriff (PDF)

The regenerative capacity of zebrafish reverses cardiac failure caused by genetic cardiomyocyte depletion

Development (Cambridge), 2011-08, Vol.138 (16), p.3421-3430

2011

Volltextzugriff (PDF)

MyPathway Human Epidermal Growth Factor Receptor 2 Basket Study: Pertuzumab + Trastuzumab Treatment of a Tissue-Agnostic Cohort of Patients With Human Epidermal Growth Factor Receptor 2-Altered Advanced Solid Tumors

Journal of clinical oncology, 2024-01, Vol.42 (3), p.258-265

2024

Volltextzugriff (PDF)

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

The New England journal of medicine, 2021-01, Vol.384 (3), p.229-237

2021

Volltextzugriff (PDF)

A Phase I/Ib Study of Enzalutamide Alone and in Combination with Endocrine Therapies in Women with Advanced Breast Cancer

Clinical cancer research, 2017-08, Vol.23 (15), p.4046-4054

2017

Volltextzugriff (PDF)

High-volume hemofiltration in adult burn patients with septic shock and acute kidney injury: a multicenter randomized controlled trial

Critical care (London, England), 2017-11, Vol.21 (1), p.289-289, Article 289

2017

Volltextzugriff (PDF)

Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered with PD-L1 Inhibitor (Atezolizumab) in Advanced Solid Tumors

Clinical cancer research, 2019-06, Vol.25 (11), p.3220-3228

2019

Volltextzugriff (PDF)

A phase II trial of ixabepilone and cyclophosphamide as neoadjuvant therapy for patients with HER2-negative breast cancer: correlation of pathologic complete response with the 21-gene recurrence score

Breast cancer research and treatment, 2015-11, Vol.154 (2), p.299-308

2015

Volltextzugriff (PDF)

A cluster randomized controlled trial for a multi-level, clinic-based smoking cessation program with women in Appalachian communities: study protocol for the "Break Free" program

Addiction science & clinical practice, 2022-02, Vol.17 (1), p.11-11, Article 11

2022

Volltextzugriff (PDF)

Correction to: A cluster randomized controlled trial for a multi-level, clinic-based smoking cessation program with women in Appalachian communities: study protocol for the "Break Free" program

Addiction science & clinical practice, 2022-04, Vol.17 (1), p.21-21, Article 21

2022

Volltextzugriff (PDF)

378: Cervicovaginal MMP-9 is associated with high-risk microbial communities and spontaneous preterm birth

American journal of obstetrics and gynecology, 2020-01, Vol.222 (1), p.S251-S252

2020

Volltextzugriff (PDF)

Maternal stress, low cervicovaginal β-defensin, and spontaneous preterm birth

American journal of obstetrics & gynecology MFM, 2020-05, Vol.2 (2), p.100092-100092, Article 100092

2020

Volltextzugriff (PDF)

First‐In‐Human, First‐In‐Class, Phase I Trial of the Fucosylation Inhibitor SGN‐2FF in Patients with Advanced Solid Tumors

The oncologist (Dayton, Ohio), 2021-11, Vol.26 (11), p.925-e1918

2021

Volltextzugriff (PDF)

“I know my body better than anyone else”: a qualitative study of perspectives of people with lived experience on antimicrobial treatment decisions for injection drug use-associated infections

Therapeutic advances in infectious disease, 2023-01, Vol.10

2023

Volltextzugriff (PDF)

Hoyeraal-Hreidarsson Syndrome due to PARN Mutations: Fourteen Years of Follow-Up

Pediatric neurology, 2016-03, Vol.56, p.62-68.e1

2016

Volltextzugriff (PDF)

Intravenous Aviptadil and Remdesivir for Treatment of COVID-19-associated Hypoxemic Respiratory Failure: Randomized, Placebo-controlled Trials

The lancet respiratory medicine, 2023-06, Vol.11 (9), p.791-803

2023

Volltextzugriff (PDF)

Abstract 5551: SGN-2FF: A small-molecule inhibitor of fucosylation modulates immune cell activity in preclinical models and demonstrates pharmacodynamic activity in early phase 1 analysis

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.5551-5551

2018

Volltextzugriff (PDF)

Analysis of Outcomes Associated With Outpatient Management of Nonoperatively Treated Patients With Appendicitis

JAMA network open, 2022-07, Vol.5 (7), p.e2220039-e2220039

2022

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(29)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(18)
Science & Technology
(18)
Humans
(12)
Adult
(8)
Female
(6)
Aged
(5)
Clinical Trials
(5)
Male
(5)
Middle Aged
(5)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(4)
Oncology
(4)
Treatment Outcome
(4)
Care And Treatment
(3)
General & Internal Medicine
(3)
Neoplasm Staging
(3)
Patients
(3)
Risk Factors
(3)
Surgery
(3)
Aged, 80 And Over
(2)
Allergy
(2)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Immunologic components in human milk and allergic diseases with focus on food allergy

Cow’s Milk Protein Allergy in Term and Preterm Infants: Clinical Manifestations, Immunologic Pathophysiology, and Management Strategies

Association of oral habits with food allergy and comorbid atopic disease

Oral Habits and Association with Lower Rate of Asthma and Seasonal Allergies

Is It Time to Offer Peanut Oral Immunotherapy to Toddlers?

Association of Oral Habits with Food Allergy and Co-morbid Atopic Disease

The regenerative capacity of zebrafish reverses cardiac failure caused by genetic cardiomyocyte depletion

MyPathway Human Epidermal Growth Factor Receptor 2 Basket Study: Pertuzumab + Trastuzumab Treatment of a Tissue-Agnostic Cohort of Patients With Human Epidermal Growth Factor Receptor 2-Altered Advanced Solid Tumors

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

A Phase I/Ib Study of Enzalutamide Alone and in Combination with Endocrine Therapies in Women with Advanced Breast Cancer

High-volume hemofiltration in adult burn patients with septic shock and acute kidney injury: a multicenter randomized controlled trial

Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered with PD-L1 Inhibitor (Atezolizumab) in Advanced Solid Tumors

A phase II trial of ixabepilone and cyclophosphamide as neoadjuvant therapy for patients with HER2-negative breast cancer: correlation of pathologic complete response with the 21-gene recurrence score

A cluster randomized controlled trial for a multi-level, clinic-based smoking cessation program with women in Appalachian communities: study protocol for the "Break Free" program

Correction to: A cluster randomized controlled trial for a multi-level, clinic-based smoking cessation program with women in Appalachian communities: study protocol for the "Break Free" program

378: Cervicovaginal MMP-9 is associated with high-risk microbial communities and spontaneous preterm birth

Maternal stress, low cervicovaginal β-defensin, and spontaneous preterm birth

First‐In‐Human, First‐In‐Class, Phase I Trial of the Fucosylation Inhibitor SGN‐2FF in Patients with Advanced Solid Tumors

“I know my body better than anyone else”: a qualitative study of perspectives of people with lived experience on antimicrobial treatment decisions for injection drug use-associated infections

Hoyeraal-Hreidarsson Syndrome due to PARN Mutations: Fourteen Years of Follow-Up

Association of Patient Belief About Success of Antibiotics for Appendicitis and Outcomes: A Secondary Analysis of the CODA Randomized Clinical Trial

Intravenous Aviptadil and Remdesivir for Treatment of COVID-19-associated Hypoxemic Respiratory Failure: Randomized, Placebo-controlled Trials

Phase I Study of the Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Navoximod (GDC-0919) Administered with PD-L1 Inhibitor (Atezolizumab) in Patients with Advanced Solid Tumors

Abstract 5551: SGN-2FF: A small-molecule inhibitor of fucosylation modulates immune cell activity in preclinical models and demonstrates pharmacodynamic activity in early phase 1 analysis

Analysis of Outcomes Associated With Outpatient Management of Nonoperatively Treated Patients With Appendicitis

Suchergebnisse filtern